Sirpa Leppa (Sirpa Leppä)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 27

Top Topics

Epstein Barr Virus

Hodgkin Lymphoma

Diffuse Large B Cell Lymphoma

Top Venues

Blood cancer journal

European journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Mats Jerkeman, Arne Kolstad, Martin Hutchings, Annika Pasanen, Leo Meriranta, Carsten Utoft Niemann, Rasmus Rask Kragh Jørgensen, Tarec Christoffer El-Galaly, Jon Riise, Sirpa Leppa, Jacob Haaber Christensen, Kristina Sonnevi, Lone Bredo Pedersen, Karin Fahl Wader, Ingrid Glimelius
MRD-driven treatment with venetoclax-R2 in mantle cell lymphoma: the Nordic Lymphoma Group MCL7 VALERIA trial. Blood advances 8 (2) (2024)
Mats Jerkeman, Arne Kolstad, Martin Hutchings, Annika Pasanen, Leo Meriranta, Carsten Utoft Niemann, Rasmus Rask Kragh Jørgensen, Tarec Christoffer El-Galaly, Jon Riise, Sirpa Leppa, Jacob Haaber Christensen, Kristina Sonnevi, Lone Bredo Pedersen, Karin Fahl Wader, Ingrid Glimelius
MRD-driven treatment with venetoclax-R2 in mantle cell lymphoma: the Nordic Lymphoma Group MCL7 VALERIA trial. Blood advances 8 (2) (2024)
Leo Meriranta, Selma Sorri, Kanutte Huse, Xiaonan Liu, Ivana Spasevska, Sadia Zafar, Iftekhar Chowdury, Olli Dufva, Eerika Sahlberg, Luka Tandaric, Marja-Liisa Karjalainen-Lindsberg, Marko M Hyytiäinen, Markku Varjosalo, June Helen Myklebust, Sirpa Leppa
Disruption of KLHL6 Fuels Oncogenic Antigen Receptor Signaling in B-Cell Lymphoma. Blood cancer discovery 5 (5) (2024)
Mats Jerkeman, Arne Kolstad, Martin Hutchings, Annika Pasanen, Leo Meriranta, Carsten Utoft Niemann, Rasmus Rask Kragh Jørgensen, Tarec Christoffer El-Galaly, Jon Riise, Sirpa Leppa, Jacob Haaber Christensen, Kristina Sonnevi, Lone Bredo Pedersen, Karin Fahl Wader, Ingrid Glimelius
MRD-driven treatment with venetoclax-R2 in mantle cell lymphoma: the Nordic Lymphoma Group MCL7 VALERIA trial. Blood advances 8 (2) (2024)
Mats Jerkeman, Arne Kolstad, Martin Hutchings, Annika Pasanen, Leo Meriranta, Carsten Utoft Niemann, Rasmus Rask Kragh Jørgensen, Tarec Christoffer El-Galaly, Jon Riise, Sirpa Leppa, Jacob Haaber Christensen, Kristina Sonnevi, Lone Bredo Pedersen, Karin Fahl Wader, Ingrid Glimelius
MRD-driven treatment with venetoclax-R2 in mantle cell lymphoma: the Nordic Lymphoma Group MCL7 VALERIA trial. Blood advances 8 (2) (2024)
Leo Meriranta, Selma Sorri, Kanutte Huse, Xiaonan Liu, Ivana Spasevska, Sadia Zafar, Iftekhar Chowdury, Olli Dufva, Eerika Sahlberg, Luka Tandaric, Marja-Liisa Karjalainen-Lindsberg, Marko M Hyytiäinen, Markku Varjosalo, June Helen Myklebust, Sirpa Leppa
Disruption of KLHL6 Fuels Oncogenic Antigen Receptor Signaling in B-cell Lymphoma. Blood cancer discovery (2024)
Mats Jerkeman, Arne Kolstad, Martin Hutchings, Annika Pasanen, Leo Meriranta, Carsten Utoft Niemann, Rasmus Rask Kragh Jørgensen, Tarec Christoffer El-Galaly, Jon Riise, Sirpa Leppa, Jacob Haaber Christensen, Kristina Sonnevi, Lone Bredo Pedersen, Karin Fahl Wader, Ingrid Glimelius
MRD-driven treatment with venetoclax-R2 in mantle cell lymphoma: the Nordic Lymphoma Group MCL7 VALERIA trial. Blood advances 8 (2) (2024)
Maja Ludvigsen, Amanda Jessica Campbell, Marie Beck Enemark, Trine Engelbrecht Hybel, Marja-Liisa Karjalainen-Lindsberg, Klaus Beiske, Mette Bjerre, Lars Møller Pedersen, Harald Holte, Sirpa Leppa, Judit Meszaros Jørgensen, Bent Honoré
Proteomics uncovers molecular features for relapse risk stratification in patients with diffuse large B-cell lymphoma. Blood cancer journal 13 (1) (2023)
Ilja Kalashnikov, Tomas Tanskanen, Leevi Viisanen, Nea Malila, Sirkku Jyrkkiö, Sirpa Leppa
Transformation and survival in marginal zone lymphoma: a Finnish nationwide population-based study. Blood cancer journal 13 (1) (2023)
Hector J Monzo, Kerttu Kalander, Marko M Hyytiäinen, Endrit Elbasani, Johanna Wall, Lidia Moyano-Galceran, Jayendrakishore Tanjore Ramanathan, Joonas J J Jukonen, Pirjo Laakkonen, Ari Ristimäki, Joseph W Carlson, Kaisa Lehti, Sahar Salehi, Pauli Puolakkainen, Caj Haglund, Hanna Seppänen, Sirpa Leppa, Päivi M Ojala
Efficacy and safety of glycosphingolipid SSEA-4 targeting CAR-T cells in an ovarian carcinoma model. Molecular cancer therapeutics (2023)
Laura Kohtamäki, Suvi-Katri Leivonen, Siru Mäkelä, Susanna Juteau, Sirpa Leppa, Micaela M Hernberg
Intra-patient evolution of tumor microenvironment in the pathogenesis of treatment-naïve metastatic melanoma patients. Acta oncologica (Stockholm, Sweden) (2023)
Mats Jerkeman, Arne Kolstad, Martin Hutchings, Annika Pasanen, Leo Meriranta, Carsten Utoft Niemann, Rasmus Rask Kragh Jørgensen, Tarec Christoffer El-Galaly, Jon Riise, Sirpa Leppa, Jacob Haaber Christensen, Kristina Sonnevi, Lone Bredo Pedersen, Karin Fahl Wader, Ingrid Glimelius
MRD-driven treatment with venetoclax-R2 in mantle cell lymphoma: the Nordic Lymphoma Group MCL7 VALERIA trial. Blood advances (2023)
Ilja Kalashnikov, Tomas Tanskanen, Leevi Viisanen, Nea Malila, Sirkku Jyrkkiö, Sirpa Leppa
Transformation and survival in marginal zone lymphoma: a Finnish nationwide population-based study. Blood cancer journal 13 (1) (2023)
Kristiina Karihtala, Suvi-Katri Leivonen, Marja-Liisa Karjalainen-Lindsberg, Fong Chun Chan, Christian Steidl, Teijo Pellinen, Sirpa Leppa
Checkpoint protein expression in the tumor microenvironment defines the outcome of classical Hodgkin lymphoma patients. Blood advances 6 (6) (2022)
Leo Meriranta, Amjad Alkodsi, Annika Pasanen, Maija Lepistö, Parisa Mapar, Yngvild Nuvin Blaker, Judit Meszaros Jørgensen, Marja-Liisa Karjalainen-Lindsberg, Idun Fiskvik, Lars Tore G Mikalsen, Matias Autio, Magnus Björkholm, Mats Jerkeman, Øystein Fluge, Peter de Nully Brown, Sirkku Jyrkkiö, Harald Holte, Esa Pitkänen, Pekka Ellonen, Sirpa Leppa
Molecular features encoded in the ctDNA reveal heterogeneity and predict outcome in high-risk aggressive B-cell lymphoma. Blood 139 (12) (2022)
Heli Vajavaara, Suvi-Katri Leivonen, Judit Meszaros Jørgensen, Harald Holte, Sirpa Leppa
Low lymphocyte-to-monocyte ratio predicts poor outcome in high-risk aggressive large B-cell lymphoma. EJHaem 3 (3) (2022)
Matias Autio, Suvi-Katri Leivonen, Oscar Brück, Marja-Liisa Karjalainen-Lindsberg, Teijo Pellinen, Sirpa Leppa
Clinical Impact of Immune Cells and Their Spatial Interactions in Diffuse Large B-Cell Lymphoma Microenvironment. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (4) (2022)
Ilja Kalashnikov, Tomas Tanskanen, Janne M Pitkäniemi, Nea Malila, Sirkku Jyrkkiö, Sirpa Leppa
Transformation and outcome of nodular lymphocyte predominant Hodgkin lymphoma: a Finnish Nationwide population-based study. Blood cancer journal 11 (12) (2021)
Marjukka Pollari, Suvi-Katri Leivonen, Sirpa Leppa
Testicular Diffuse Large B-Cell Lymphoma-Clinical, Molecular, and Immunological Features. Cancers 13 (16) (2021)
Heli Vajavaara, Julie Bondgaard Mortensen, Suvi-Katri Leivonen, Ida Monrad Hansen, Maja Ludvigsen, Harald Holte, Judit Jørgensen, Mette Bjerre, Francesco d'Amore, Sirpa Leppa
Soluble PD-1 but Not PD-L1 Levels Predict Poor Outcome in Patients with High-Risk Diffuse Large B-Cell Lymphoma. Cancers 13 (3) (2021)
Marjukka Pollari, Teijo Pellinen, Marja-Liisa Karjalainen-Lindsberg, Pirkko-Liisa Kellokumpu-Lehtinen, Suvi-Katri Leivonen, Sirpa Leppa
Adverse prognostic impact of regulatory T-cells in testicular diffuse large B-cell lymphoma. European journal of haematology 105 (6) (2020)
Kristiina Karihtala, Suvi-Katri Leivonen, Oscar Brück, Marja-Liisa Karjalainen-Lindsberg, Mohamed El Missiry, Teijo Pellinen, Sirpa Leppa
Prognostic Impact of Tumor-Associated Macrophages on Survival Is Checkpoint Dependent in Classical Hodgkin Lymphoma. Cancers 12 (4) (2020)
Pauli Vähämurto, Marjukka Pollari, Michael R Clausen, Francesco d'Amore, Sirpa Leppa, Susanna Mannisto
Low Absolute Lymphocyte Counts in the Peripheral Blood Predict Inferior Survival and Improve the International Prognostic Index in Testicular Diffuse Large B-Cell Lymphoma. Cancers 12 (7) (2020)
Pauli Vähämurto, Susanna Mannisto, Marjukka Pollari, Marja-Liisa Karjalainen-Lindsberg, Antti Aarni Mäkitie, Sirpa Leppa
Clinical features and outcome of the patients with sinonasal tract diffuse large B-cell lymphoma in the pre-rituximab and rituximab eras. European journal of haematology 102 (6) (2019)
Amjad Alkodsi, Alejandra Cervera, Kaiyang Zhang, Riku Louhimo, Leo Meriranta, Annika Pasanen, Suvi-Katri Leivonen, Harald Holte, Sirpa Leppa, Rainer Lehtonen, Sampsa Hautaniemi
Distinct subtypes of diffuse large B-cell lymphoma defined by hypermutated genes. Leukemia 33 (11) (2019)
Suvi-Katri Leivonen, Katherine Icay, Kirsi Jäntti, Ilari Siren, Chengyu Liu, Amjad Alkodsi, Alejandra Cervera, Maja Ludvigsen, Stephen Jacques Hamilton-Dutoit, Francesco d'Amore, Marja-Liisa Karjalainen-Lindsberg, Jan Delabie, Harald Holte, Rainer Lehtonen, Sampsa Hautaniemi, Sirpa Leppa
MicroRNAs regulate key cell survival pathways and mediate chemosensitivity during progression of diffuse large B-cell lymphoma. Blood cancer journal 7 (12) (2017)
Andrea B Moffitt, Sarah L Ondrejka, Matthew McKinney, Rachel E Rempel, John R Goodlad, Chun Huat Teh, Sirpa Leppa, Susanna Mannisto, Panu E Kovanen, Eric Wai-Choi Tse, Rex K H Au-Yeung, Yok-Lam Kwong, Gopesh Srivastava, Javeed Iqbal, Jiayu Yu, Kikkeri Naresh, Diego R Villa, Randy D Gascoyne, Jonathan W Said, Magdalena B Czader, Amy Chadburn, Kristy L Richards, Deepthi Rajagopalan, Nicholas S Davis, Eileen C Smith, Brooke C Palus, Tiffany J Tzeng, Jane A Healy, Patricia L Lugar, Jyotishka Datta, Cassandra Love, Shawn Levy, David B Dunson, Yuan Zhuang, Eric D Hsi, Sandeep S Dave
Enteropathy-associated T cell lymphoma subtypes are characterized by loss of function of SETD2. The Journal of experimental medicine 214 (5) (2017)